Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aranesp for Anemia in Advanced Hormone Independent Prostate Cancer
NCT00381836Phase 3Terminated
- Sponsor
- Aarhus University
- Start
- Oct 2006
- Primary completion
- Feb 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anemia comparing Aranesp with Standard of Care (2 arms). Primary endpoint: The haematopoietic response at 20 weeks. Started Oct 2006; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00381836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381836.